Peregrine Ventures unveils new consortium to invest in medical startups
Peregrine Ventures, an investment firm focused on healthcare opportunities, has announced the establishment of a consortium of leading companies and research institutes that have joined its Incentive Technology Incubator.
The consortium will jointly develop and invest over NIS 300 million (approximately $90 million) in start-ups and graduates of Peregrine’s technology incubator.The new members of Peregrine’s Incentive Incubator include global pharmaceutical giant Bristol-Myers Squibb (BMS), medical devices and diagnostics company BD (Becton Dickinson and Company), Elbit Systems, and institutions such as Tel Aviv University, Ben-Gurion University of the Negev, and Shaare Zedek Medical Center, represented by Agmon & Co., Rosenberg Hacohen & Co.
Shaare Zedek’s medical experts will work alongside teams from the incubator and their portfolio of companies to make the hospital’s research resources and insights available for the benefit of relevant projects.
Read more in Calcalist.
